Evolved neural networks for high throughput Anti-HIV ligand screening

2006 IEEE Congress on Evolutionary Computation, CEC 2006

Volumn , Issue , 2006, Pages 2734-2741

  Ma, Connie Y C ^b,c   Wong, Susanna W M ^b,d   Hecht, David ^a,e   Fogel, Gary B ^a,f  

^a IEEE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMGEN INC   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e Southwestern College   (United States)

^f NATURAL SELECTION INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DISCOVERY; HIV INHIBITORS; MOLECULE DIVERSITY; STRUCTURE-ACTIVITY RELATIONSHIPS;

DRUG THERAPY; EVOLUTIONARY ALGORITHMS; LEAD COMPOUNDS; NEURAL NETWORKS; OPTIMIZATION; PROBLEM SOLVING; VIRUSES;

LIGANDS;

EID: 34547327951     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (40)

1. PhRMA Industry Profile 2003 Report: http://www.phrma.org/publications
2. Center for Drug Evaluation and Research: http://www.fda.gov/cder/rdmt
3. C. Hansch and T. Fujita (1964) J. Am Chem. Soc. Vol. 86, pp. 1616.
4. G.E. Kellogg and S.F. Semus (2003) 3D QSAR in modem Drug Design in Hillisch, A and Hilgenfeld R. (Eds.) Modern Methods of Drug Discovery, Birkhauser Verlag, Switzerland, pp. 223-241.
5. E. Ernesto, G. Patlewicz, and U. Eugenio (2003) From molecular graphs to drugs: A review on the use of topological indices in drug design and discovery. Indian J. Chem, Section A; Inorganic, Bioinorganic, Phyiscal, Theoretical & Analytical Chemistry Vol. 42A, pp. 1315-1329.
6. P.V. Desai and E.C. Coutinho (2001) QSAR in Drug Discovery and Development. Asian Chem. Lett. Vol. 5, pp. 77-86.
7. V.J. Gillet (2003) Application of Evolutionary Algorithms to Combinatorial Library Design In Cartwright, H.M., Sztandera, L.M. (Eds.) Soft Computing Approaches in Chemistry, Springer-Verlag, Berlin, pp. 1-30.
8. S.P. Niculescu (2003) Artificial neural networks and genetic algorithms in QSAR. J. Mol. Struct. Vol. 622, pp. 71-83.
9. http://dtp.nci.nih.gov/
10. H. Hong, N. Neamati, S. Wang, M.C. Nicklaus, A. Mazumder, H. Zhao, T.R. Burke, Y. Pommier, and G.W.A. Milne (1997) Discovery of HIV-1 Integrase Inhibitors by Pharmacophore Searching, J. Med. Chem. Vol. 40:, pp. 930-936.
11. N. Neamati, H. Hong, A. Mazumder, S. Wang, S. Sunder, M.C. Nicklaus, G.W.A. Milne, B. Proksa, and Y. Pommier (1997) Depsides and Depsidones as Inhibitors of HIV-I Integrase: Discovery of Novel Inhibitors through 3D Database Searching, J. Med. Chem. Vol. 40, pp. 942-951.
12. S.Y. Tamura, P.A. Bacha, H.S. Gruver, and R.F. Nutt (2002) Data Analysis of High-Throughput Screening Results: Application of Multidomain Clustering to the NCI Anti-HCV Data Set, J Med. Chem. Vol. 45, pp. 3082-3093.
13. M.C. Nicklaus, N. Neamati, H. Hong, A. Mazumder, S. Sunder, J. Chen, G.W.A. Milne, and Y. Pommier (1997) HTV-I Integrase Pharmacophore: Discovery of Inhibitors through Three-Dimensional Database Searching, J. Med. Chem. Vol. 40, pp. 920-929.
14. http://dtp.nci.nih.gov/docs/aids/aids_data.html
15. www.cambridgesoft.com
16. th November.
17. Jaccard, P. (1901) Bulletin del la Société Vaudoisedes Sciences Naturelles Vol. 37, pp. 241-272
18. P. Willett (1998) Chemical similarity searching, J. Chem. Inf. Comput. Sci. 1998, Vol. 38, pp. 983-996
19. E.M. Duffy and W.L. Jorgensen, (2000) Prediction of Properties from Simulations: Free Energies of Solvation in Hexadecane, Octanol, and Water. J. Am. Chem. Soc. Vol. 122, pp.2878-2888.
20. W.L. Jorgensen and E.M. Duffy (2000) Prediction of drug solubility from Monte Carlo simulations. Bioorg. & Med. Chem. Lett. Vol. 10, pp. 1155-1158.
21. http://www.chemcomp.com/
22. D.B. Fogel, L.J. Fogel and V.W. Porto (1990) Evolving Neural Networks Biological Cybernetics, Vol. 63, pp. 487-493.
23. X. Yao, (1999) Evolving artificial neural networks Proceedings of the IEEE, Vol. 87, pp. 1423-1447.
24. D. Weekes and G.B. Fogel (2003) Evolutionary Optimization, Backpropagation, and Data Preparation Issues in QSAR Modeling of HIV Inhibition by HEPT Derivatives. BioSystems, Vol. 72, pp. 149-158.
25. D.B. Fogel (2006) Evolutionary Computation: Toward a New Philosophy of Machine Intelligence, IEEE Press, Piscataway, NJ, third edition.
26. R.S. Pearlman and K.M. Smith (1998) Novel Software Tools for Chemical Diversity; Persp. Drug. Disc. Des. 9/10/11, pp 339-353.
27. S.A. Wildman and G.M. Crippen, (1999) Prediction of Physiochemical Parameters by Atomic Contributions. J. Chem. Inf. Comput. Sci. Vol. 39, pp. 868-873.
28. M. Petitjean (1992) Applications of the Radius-Diameter Diagram to the Classification of Topological and Geometrical Shapes of Chemical Compounds. J. Chem. Inf. Comput. Sci. Vol. 32, pp. 331-337.
29. L.H. Hall and L.B. Kier (1991) The Molecular Connectivity Chi Indices and Kappa Shape Indices in Structure-Property Modeling. Rev. Comp. Chem. Vol. 2, pp.367-422
30. L.H. Hall and L.B. Kier (1977) The Nature of Structure-Activity Relationships and Their Relation to Molecular Connectivity. Eur. J. Med. Chem. Vol. 12, pp. 307.
31. T.I. Oprea (2000) Property Distribution of Drug-Related Chemical Databases. J. Comp. Aid. Mol. Des. Vol. 14, pp. 251-264.
32. J. Gasteiger, and M. Marsili (1980) Iterative Partial Equalization of Orbital Electronegativity - A Rapid Access to Atomic Charges. Tetrahedron. Vol. 36, pp. 3219.
33. P. Ertl, B. Rohde, and P. Selzer (2000) Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties. J. Med. Chem. Vol. 43, pp. 3714-3717.
34. M. Yazdanian, S.L. Glynn, J.L. Wright, and A. Hawi (1998) Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res, Vol. 15, pp.1490-1494.
35. J.D., Irvine, L. Takahashi, K. Lockhart, J. Cheong, J.W. Tolan, H.E. Selick, and J.R. Grove (1999) MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci. ;Vol. 88, pp. 28-33.
36. P. Stenberg, U. Norinder, K. Luthman, and P. Artursson (2001) Experimental and computational screening models for the prediction of intestinal drug absorption. J. Med. Chem. Vol. 44, pp.1927-1937.
37. R.O. Potts and R.H. Guy (1992) Predicting Skin Permeability. Pharm. Res. Vol. 9,pp. 663-669;
38. R.O. Potts and R.H. Guy (1995), Predicting Skin Permeability: II. The Effects of Molecular Size and Hydrogen Bond Activity, Pharm. Res. Vol.12, pp. 1628-1633.
39. G. Colmenarejo, A. Alvarez-Pedraglio, and J.-L. Lavandera (2001) Cheminformatic Models To Predict Binding Affinities to Human Serum Albumin. J. Med. Chem. Vol. 44, pp. 4370-4378.
40. W.L.. Jorgensen and E.M. Duffy (2002). Prediction of Drug Solubility from Structure. Adv. Drug Delivery Rev. Vol. 54, pp. 355-366.